cabotegravir,
GSK1265744,
GSK744,
N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide,
Cabotegravir,
1051375-10-0,
GSK1265744,
GSK744,
UNII-HMH0132Z1Q,
GSK1265744A,
GSK-1265744,
Cabotegravir (GSK744, GSK1265744),
GSK744 (S/GSK1265744),
HMH0132Z1Q,
CAB,
Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)-;Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)-,
Cabotegravir [USAN:INN],
GSK744 LAP,
GSK744 LA,
S/GSK1265744,
GSK 744,
744 LA,
GSK 1265744,
SCHEMBL82803,
S-265744,
Cabotegravir (JAN/USAN/INN),
Cabotegravir; GSK1265744,
CHEMBL2403238,
DTXSID50146982,
WCWSTNLSLKSJPK-LKFCYVNXSA-N,
BCP08631,
cabotegravir-gsk744-gsk1265744,
EX-A2330,
MFCD25976748,
s7766,
ZINC96927633,
AKOS027253403,
S/GSK-1265744,
CS-5078,
DB11751,
SB17101,
NCGC00386434-02,
(3S,11aR)-N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide,
Cabotegravir(GSK1265744A,GSK-744),
HY-15592,
D10548,
(3R,6S)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-6-methyl-8,11-dioxo-4-oxa-1,7-diazatricyclo[7.4.0.0?,?]trideca-9,12-diene-12-carboxamide,
(3S,11AR)-3-METHYL-5,7-DIOXO-2,3,5,7,11,11A-HEXAHYDROOXAZOLO[3,2-A]PYRIDO[1,2-D]PYRAZINE-8-CARBOXYLIC ACID,
(3S,11AR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide,
(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,11,11a-tetrahydrooxazolo[[?]]pyrido[[?]]pyrazine-8-carboxamide,
(3s,11ar)-n-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide,
D08LDB,
ACN-041362,
CID11965164,
CID 11965085,
A8566,
A16014,
(3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido [1,2-d]pyrazine-8-carboxamide,
GSK-1265744|||(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide|||S-265744,